Secondary Structure

Secondary Structure refers to local, repetitive folding patterns within a protein, primarily including alpha helices and beta sheets, stabilised by hydrogen bonding between backbone atoms. These structural motifs form the foundation of a protein's three-dimensional conformation and strongly influence stability, solubility, and biological function.

In biopharmaceutical development, secondary structure assessment supports biologics characterisation, comparability studies, and stability testing. Analytical methods such as circular dichroism (CD) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, and hydrogen-deuterium exchange approaches help confirm that manufacturing changes or storage conditions do not disrupt structural integrity. Because subtle alterations in secondary structure can impact potency, immunogenicity, and aggregation risk, maintaining consistent folding profiles remains critical for product quality and regulatory confidence. Regulatory submissions include secondary structure data as part of higher-order structure characterisation supporting biosimilarity assessments and comparability studies following manufacturing changes. As analytical capabilities advance and biologic complexity increases, secondary structure analysis remains a foundational element of comprehensive product characterisation.